INTO – Inhalation Together

INTO – Inhalation Together is a collaborative alliance launched in February 2022 by three specialized European companies (Sterling SPA, Harro Hoefliger and DFE Pharma), combining decades of experience in inhalation sciences. INTO functions as a “single gateway” for the development of dry-powder inhalation (DPI) products: from API characterization, formulation development and analytical services, to regulatory and project-management support — all delivered through a unified, coordinated approach. The rebrand aimed to reflect INTO’s core identity: scientific precision, streamlined collaboration, and clarity in complexity. The design language follows a minimal, modern aesthetic, conveying trust, professionalism and efficiency — aligned with INTO’s mission to simplify and accelerate inhalation product development.